Results with Optilume consistent in clinical trials and real world, regardless of prostate ...

Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, today announced a strategic collaboration with HNL Lab Medicine, a leading multi-regional medical laboratory in the ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

Ibex Medical Analytics (Ibex), the global leader in clinical-grade AI-powered pathology, today announced the launch of Ibex 4, its next-generation platform. Built on Ibex's clinic ...

Prior results with the drug in other surgical settings have been mixed ...

Procept BioRobotics today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

When Janice Johnson went to the hospital for what she thought was food poisoning, she had no idea it would lead to a cancer diagnosis in her 40s. Despite her immediate fear, Janice refused to accept a ...

The PAUSE-URO study evaluated the safety of a new protocol for patients using direct oral anticoagulants (DOACs) prior to elective urologic surgery.

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

Drs Uzzo, Chung, and Croll of Fox Chase Cancer Center at Temple University Health discuss top presentations from the ASCO Genitourinary Cancers Symposium 2026. The American Society of Clinical ...